Activation marker F1+2 in patients treated with recombinant factor VIIa

被引：0
|
作者：
Ingerslev, J
Holm, M
Christiansen, K
Knudsen, L
机构：
[1] AARHUS UNIV HOSP, DEPT CLIN IMMUNOL, CTR HAEMOPHILIA & THROMBOSIS, DK-8200 AARHUS N, DENMARK
[2] AARHUS UNIV HOSP, DEPT HAEMATOL, DK-8200 AARHUS N, DENMARK
来源：
THROMBOSIS AND HAEMOSTASIS | 1997年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：PS344 / PS344
页数：1
相关论文
共 50 条
  • [21] Prophylactic recombinant factor VIIa in haemophilia patients with inhibitors
    Young, G
    McDaniel, M
    Nugent, DJ
    HAEMOPHILIA, 2005, 11 (03) : 203 - 207
  • [22] Unlabeled uses of factor VIIa (recombinant) in pediatric patients
    Hong, Irene
    Stachnik, Joan
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (22) : 1909 - 1919
  • [23] Recombinant factor VIIa in trauma patients with the 'triad of death'
    Mitra, Biswadev
    Cameron, Peter A.
    Parr, Michael J.
    Phillips, Louise
    INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2012, 43 (09): : 1409 - 1414
  • [24] Experiences with recombinant human factor VIIa in patients with thrombocytopenia
    Goodnough, LT
    SEMINARS IN HEMATOLOGY, 2004, 41 (01) : 25 - 29
  • [25] Use of Recombinant Factor VIIa in Critically Ill Patients
    Perreault, Marc M.
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2006, 59 : 45 - 46
  • [26] Clinical experience with recombinant factor VIIa in patients with thrombocytopenia
    Kristensen, J
    Killander, A
    Hippe, E
    Helleberg, C
    Ellegard, J
    Holm, M
    Kutti, J
    Mellqvist, UH
    Johansson, JE
    Glazer, S
    Hedner, U
    HAEMOSTASIS, 1996, 26 : 159 - 164
  • [27] A patient with Glanzmann thrombasthenia and epistaxis successfully treated with recombinant factor VIIa
    Tengborn, L
    Petruson, B
    THROMBOSIS AND HAEMOSTASIS, 1996, 75 (06) : 981 - 982
  • [28] BivalirudinBlood coagulation disorders treated with recombinant factor VIIa: case report
    Reactions Weekly, 2011, 1375 (1) : 8 - 8
  • [29] The risk of thrombotic events in neonates treated with recombinant factor VIIa.
    Puetz, John
    Darling, Ginger
    Brabec, Petr
    Blatny, Jan
    Mathew, Prasad
    BLOOD, 2007, 110 (11) : 938A - 938A
  • [30] Prophylactic effect of recombinant factor VIIa in factor VII deficient patients
    Mathijssen, NCJ
    Masereeuw, RS
    Verbeek, K
    Lavergne, JM
    Costa, JM
    van Heerde, WL
    Nováková, IRO
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 (04) : 494 - 499
12345